Pathway Diagnostics: Biomarker Development, Testing and Commercialization Ask Us How

Biomarker Portfolio

Today, our biomarker portfolio includes assays in the areas of infectious disease, oncology, musculoskeletal and CNS disorders. Biomarkers are also in development for other disease areas including cardiovascular, inflammatory and autoimmune disorders.

What's New "Announcing SensiTrop™ II HIV co-receptor tropism assay, combining the sensitivity of heteroduplex tracking and the specificity of DNA sequence analysis "
©2007 PathwayDX.com. Privacy Policy.